As Organic Q1 Revenues Miss Target, Invitrogen to Add Sales Staff in China | GenomeWeb

Organic first-quarter revenue growth at Invitrogen missed the company's internal targets by as much as half, though total receipts increased 10 percent to $277 million year over year, Invitrogen reported late last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.